#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastrointestinal disorder Congenital cystic kidney disease Leiomyosarcoma metastatic Vaginal cancer Philadelphia positive acute lymphocytic leukaemia Narcolepsy Turner's syndrome Alport's syndrome Immune-mediated myositis Phenylketonuria Leber's congenital amaurosis Liposarcoma recurrent Neutropenia Acute myeloid leukaemia (in remission) Fungal infection More trials…

    Learn about Rare Diseases

    Haemophilia B without inhibitors – Basic Information Small intestine leiomyosarcoma – Life with Disease Osteosarcoma – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Mantle cell lymphoma stage IV – Basic Information Erdheim-Chester disease – Trials in Disease Progressive supranuclear palsy – Life with Disease Chordoma – Diagnostics Primary mediastinal large B-cell lymphoma – Basic Information SAPHO syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vericiguat Vitamin A Bp Tasipimidine SEVABERTINIB Digitoxin Sodium Iodide Ianalumab Sodium Chloride Solution 0.9% Baloxavir Marboxil Fluticasone Furoate Mavacamten Sodium Nitrite Solifenacin Succinate [14C] DC-806 Metolazone Dexmedetomidine Hydrochloride POLYMYXIN B SULFATE Tramadol Hydrochloride Motixafortide ULEFNERSEN More therapies…

    Learn about Your Condition

    Metabolic surgery Myelofibrosis Oesophageal achalasia Pulmonary hypertension Erythema migrans Hypophosphatasia Hip arthroplasty Malignant lymphoid neoplasm Partial seizures Osteomyelitis Mantle cell lymphoma stage IV Childhood asthma Large cell lung cancer Medulloblastoma Neurofibromatosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nasopharyngeal cancer

  • Study of toripalimab, cisplatin and gemcitabine combination as first treatment for patients with recurrent or metastatic nasopharyngeal cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nasopharyngeal cancer
    Investigated Drugs:
    • Toripalimab
    • Cisplatin
    • Gemcitabine
    Italy

  • Evaluating Somatostatin Receptor 2 Expression Using [68Ga]Ga-DOTA-TOC PET/CT Imaging in Patients with Epstein-Barr Virus Associated Nasopharyngeal Carcinoma

    Recruiting

    1 1 1
    Investigated Diseases:
    • Nasopharyngeal cancer
    The Netherlands

  • Study of nivolumab treatment for patients with nasopharyngeal cancer who did not respond to or worsened after platinum chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Keratinising squamous cell carcinoma of nasopharynx
    • Nasopharyngeal cancer
    • Nasopharyngeal cancer recurrent
    Investigated Drugs:
    • Nivolumab
    Poland

  • Study of Nivolumab, Cisplatin, and 5-Fluorouracil for Children and Adults with EBV-Positive Nasopharyngeal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Nasopharyngeal cancer
    Investigated Drugs:
    • Interferon Beta-1A
    • Carboplatin
    • Cisplatin
    Germany

  • Study of Pembrolizumab and Olaparib for Adults with Recurrent or Metastatic, Platinum-Resistant Nasopharyngeal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Nasopharyngeal cancer
    Investigated Drugs:
    • Olaparib
    • Pembrolizumab
    Italy

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!